Human Medicine:

Press Statement: SYNLAB UK & Ireland Confirmed as Preferred NHS Strategic Partner

21 January 2020

SYNLAB UK & Ireland has been confirmed as the preferred strategic partner to transform and deliver NHS pathology services in South East London. SYNLAB UK & Ireland’s Chief Executive, Arnaud Gueny, has issued the following statement:

I am pleased to confirm that, following an evaluation process, the NHS has identified SYNLAB UK & Ireland as their preferred strategic partner to transform and deliver pathology services in South East London.
However, the procurement process is ongoing and no contract has been awarded. For this reason, confidentiality requirements remain in place and we are unable to provide any further information or comment at this time.
We will be pleased to provide more details as soon as the process is concluded.

Arnaud Gueny, Chief Executive for SYNLAB UK and Ireland,
Latest Human Medicine News
New Pathology Partnership to Transform Patient Care in UK Capital

1st April 2021 A partnership that will transform pathology services and help to improve the quality of patient care across South East London has today…

Read More (about 'New Pathology Partnership to Transform Patient Care in UK Capital')
SYNLAB LABORATORY SERVICES 2020 ROUND UP

2020 was a challenging year for everyone. We’d like to thank all of our customers for their continued loyalty last year, we look forward to…

Read More (about 'SYNLAB LABORATORY SERVICES 2020 ROUND UP')
SYNLAB partners with Bristol Airport to provide first class Covid-19 testing service

15th December 2020 SYNLAB is teaming up with Bristol Airport to provide its customers with access to a high quality Covid-19 testing service which could…

Read More (about 'SYNLAB partners with Bristol Airport to provide first class Covid-19 testing service')
Press Statement: SYNLAB UK & Ireland Announced As Partner In Major Pathology Partnership Contract

6th October 2020 We are delighted to announce that SYNLAB UK & Ireland will become the new pathology partner to Guy’s and St Thomas’ NHS…

Read More (about 'Press Statement: SYNLAB UK & Ireland Announced As Partner In Major Pathology Partnership Contract')
SYNLAB Announce Agreement with Arquer Diagnostics for Bladder Cancer Testing

13 July 2020 SYNLAB UK & Ireland and Arquer Diagnostics, a UK-based company committed to manufacturing and marketing innovative, non-invasive tests for diagnosing and monitoring…

Read More (about 'SYNLAB Announce Agreement with Arquer Diagnostics for Bladder Cancer Testing')
SYNLAB Laboratory Services Maintains ISO 15189:2012 UKAS Accreditation

7th April 2020 – SYNLAB Laboratory Services, part of Europe’s leading medical diagnostics provider SYNLAB Group, is pleased to announce that the company has successfully…

Read More (about 'SYNLAB Laboratory Services Maintains ISO 15189:2012 UKAS Accreditation')